OpenScience.ink

4 days ago • Pediatric obesity

Liraglutide's impact on how much energy teenagers with ongoing obesity eat after stomach surgeryEffects of Liraglutide on Energy Intake in Adolescents With Persistent Obesity After Vertical Sleeve Gastrectomy.

📖 Top 20% JournalArticle

4 days ago • European journal of endocrinology

Safety of diabetes drugs that target GLP-1 receptors in hormone-related tumorsSafety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms.

Article

4 days ago • Cardiovascular diabetology. Endocrinology reports

AI-based chest x-rays may detect hidden heart relaxation problems in diabetes and obesity and track responses to diabetes medicationsAI-enabled chest x-ray potentially detects subclinical diastolic dysfunction in diabesity and monitors its functional responses to GLP-1 or GLP-1/GIP receptor agonists: initial exploration and proof-of-concept.

Article

5 days ago • Cureus

Weight Regain After Stopping Weight Loss Medications: A Review and Combined AnalysisPost-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis.

Article

5 days ago • Clinical pharmacology and therapeutics

Patterns of Prescriptions for Glucagon-Like Peptide-1 Drugs and Their Links to Mental Health ConditionsPrescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.

🥉 Top 5% JournalArticle

5 days ago • Frontiers in neuroanatomy

How GLP-1 signals in the brain's reward center may influence reward and metabolismNucleus accumbens GLP-1 signaling and its role in reward and metabolic regulation: a systematic review.

📖 Top 20% JournalSystematic Review

5 days ago • Biologie aujourd'hui

Changes in How Doctors Manage Obesity[Changes in obesity management: The clinician's perspective].

English Abstract

5 days ago • Biologie aujourd'hui

A History of GLP-1 and GIP Hormones: From Body Signals to Versatile Medicines[An historical overview of GLP-1/GIP incretins. From hormone to "swiss-army knife" medications].

Historical Article

5 days ago • JPEN. Journal of parenteral and enteral nutrition

Using Glucagon-Like Peptide-1 Medicines to Manage High Output Stoma in AdultsGlucagon-like peptide-1 analogues in the management of high output stoma in adult patients: A narrative review.

📖 Top 20% JournalArticle

5 days ago • Expert review of cardiovascular therapy

Early kidney function changes may not explain heart risk with dapagliflozin and semaglutide treatment in real-world patientsEarly changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study.

📖 Top 30% JournalArticle

5 days ago • Cardiovascular diabetology. Endocrinology reports

Tirzepatide use in repeated pancreatitis caused by high triglycerides and type 2 diabetes: a case reportTirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report.

Article

5 days ago • Diabetology & metabolic syndrome

Possible benefits of GLP-1 receptor activators and SGLT2 blockers for nerve damage in diabetesTherapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal.

📖 Top 20% JournalArticle

5 days ago • Medicine

Semaglutide’s safety and effectiveness for weight loss in obese people without diabetesEffectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis.

📖 Top 50% JournalSystematic Review

5 days ago • Endocrinology, diabetes & metabolism

Tirzepatide and SGLT2 Inhibitors for Heart Failure with Normal Pumping and Obesity: Moving Toward New Treatments for Heart and Metabolic HealthTirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era.

📖 Top 20% JournalArticle

5 days ago • Journal of the American Heart Association

Heart Effects of Glucagon Receptor Signals Alone and With Glucagon-Like Peptide-1 Signals in Multi-Target DrugsCardiovascular Effects of Glucagon Receptor Signaling Alone and Combined With Glucagon-Like Peptide-1 Receptor Signaling in Multiagonists: A Narrative Review With a Translational Focus.

🥉 Top 5% JournalArticle

5 days ago • Therapeutic advances in endocrinology and metabolism

Tirzepatide's effects on heart health beyond blood sugar controlBeyond glycemic control: clinical cardiovascular effects of tirzepatide-a narrative review.

🎖️ Top 10% JournalArticle

5 days ago • Indian journal of ophthalmology

The potential benefits and challenges of diabetes drugs for treating unexplained high pressure in the brainThe emerging role of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: Therapeutic potential and challenges.

📖 Top 30% JournalArticle

5 days ago • The bone & joint journal

Glucagon-like peptide-1 receptor agonists linked to better recovery within 90 days after hip and knee replacement surgeryGlucagon-like peptide-1 receptor agonists are associated with improved 90-day outcomes after total hip and knee arthroplasty : a systematic review and meta-analysis.

🥉 Top 5% JournalSystematic Review

5 days ago • Endocrine

Timing of GLP-1 receptor agonist treatment in pregnancy-related high blood pressure disordersHypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.

Systematic Review

5 days ago • Cureus

Changes in Outpatient Use and Dosage of Tirzepatide in Japan Based on National Prescription DataOutpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data.

Article

5 days ago • Molecular neurobiology

Multiple Potential Treatments Using GLP-1 and GIP Receptor Activators for Spinal Cord InjuryThe Pleiotropic Therapeutic Perspectives of GLP-1 and GIP Receptor Agonists in Spinal Cord Injury: A Narrative Review.

🎖️ Top 10% JournalArticle

6 days ago • Frontiers in endocrinology

Short-term oleoylethanolamide (TRPTI™) supplements increase gut hormone responsesAcute TRPTI™ (oleoylethanolamide) supplementation enhances incretin hormone responses: a fixed-sequence crossover study.

🎖️ Top 10% JournalRandomized Controlled Trial

6 days ago • Cureus

Effectiveness and Safety of Two- and Three-Target GLP-1 Drugs for Fatty Liver Disease and Liver InflammationEfficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis.

Article

6 days ago • Frontiers in endocrinology

Dietary fibers that may increase natural GLP-1 levels and feelings of fullnessDietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review.

🎖️ Top 10% JournalSystematic Review

6 days ago • medRxiv : the preprint server for health sciences

Using Negative Controls to Improve Real-World Outcome StudiesDistributional Diagnosis and Calibration with Negative Controls for Outcome-wide Real-world Evidence.

Preprint

6 days ago • Obesity (Silver Spring, Md.)

Testing oral GLP-1RA TERN-601 in adults with obesity or overweight: early phase placebo-controlled studies with increasing dosesOral GLP-1RA TERN-601 for Adults With Obesity/Overweight: Placebo-Controlled, Multiple-Ascending-Dose, Phase 1 and 2 Studies.

🎖️ Top 10% JournalArticle

6 days ago • Cureus

Heart Health and Safety of Glucagon-Like Peptide-1 Drugs in Type 2 Diabetes: A Review and Analysis of Clinical TrialsComparative Cardiovascular Outcomes and Safety Profiles of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Trials.

Article

6 days ago • Frontiers in artificial intelligence

Using machine learning to predict blood sugar control and weight loss in people taking GLP-1 receptor drugsMachine learning algorithms for predicting glycemic control and weight loss outcomes in GLP-1 receptor agonist users.

📖 Top 20% JournalArticle

6 days ago • Obesity pillars

Nutrition advice for glucagon-like peptide treatments: Consensus from Asian Indian expertsNutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation.

📖 Top 20% JournalArticle

6 days ago • Lancet (London, England)

Effectiveness and safety of once-weekly injected zenagamtide, a new drug targeting blood sugar and appetite hormones, in type 2 diabetesEfficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

🥇 Top 1% JournalArticle

← prevpage 2 of 14next →

Latest GLP-1 Therapies Research Papers